Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM207A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TLE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUVBL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM58A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FDX1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAA38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC85B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STARD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IMP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC4A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ARAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RARA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NMRAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6890 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on